Concerning the debate about homocysteine, B vitamins, and dementia

It is important to identify modifiable risk factors for dementia and to introduce policies to implement their modification. The Lancet Commission on Dementia Prevention, Intervention and Care failed to identify raised plasma homocysteine as a risk factor, despite considerable evidence; hence there i...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Journal of Alzheimer's disease Ročník 106; číslo 3; s. 920
Hlavní autoři: Miller, Joshua W, McCaddon, Andrew, Yu, Jin-Tai, Hooshmand, Babak, Refsum, Helga, Smith, A David
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 01.08.2025
Témata:
Dementia - blood
Dementia - prevention & control
Homocysteine - blood
Humans
Risk Factors
Vitamin B Complex
homocysteine
folate
B12
B6
dementia
Alzheimer's disease
risk factor
ISSN:1875-8908, 1875-8908
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:It is important to identify modifiable risk factors for dementia and to introduce policies to implement their modification. The Lancet Commission on Dementia Prevention, Intervention and Care failed to identify raised plasma homocysteine as a risk factor, despite considerable evidence; hence there is a need for a debate on this matter.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1875-8908
1875-8908
DOI:10.1177/13872877251350297